Back

Impact of atherogenic lipoproteins and inflammatory markers on silent atherosclerosis

31 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Lipids and cardiovascular risk (2) Lipids ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Nicolai Sandau

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

6 More presentations in this session

Presentation thumbnail
Lipid markers and age differences in atherosclerotic cardiovascular disease risk
Miss H. Su (Leuven, BE)
Abstract
Presentation thumbnail
Contemporary paediatric lipid percentiles in 5–14-year-olds: a population-based cross-sectional analysis
Doctor J. Krefting (Munich, DE)
Abstract
Presentation thumbnail
Risk-weighted apolipoprotein B in patients hospitalized for acute coronary syndrome: characteristics associated with discordance with measured apolipoprotein B levels.
Mr A. Meseguer Hernandez (Cartagena, ES)
Abstract
Presentation thumbnail
Predicted change in 10-year cardiovascular risk one year after initiation of bempedoic acid-based therapy in the MILOS study
Professor K. Parhofer (Munich, DE)
Abstract
Presentation thumbnail
Current non-HDL cholesterol treatment target insufficiently captures residual cardiovascular risk in very-high risk patients
Doctor M. Hansen (Aarhus, DK)
Abstract

Access the full session

Session thumbnail
Lipids and cardiovascular risk (2)

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Residual atherosclerotic risk in older patients with ASCVD: where hsCRP meets Lp(a)
30 August 2025
thumbnail
Congress Presentation
NEU1 increases monocyte and macrophage-mediated inflammation and may act as a potential modulator of atherosclerosis
21 April 2018
thumbnail
Congress Presentation
Association between neutrophil count, LDL-C, and long-term carotid plaque progression
30 August 2025
thumbnail
Congress Presentation
Exploring the mediating role of inflammation in the link between urinary copper and dyslipidemia
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources